Frank F.
About Frank F.
Frank F. is an Associate Director of Process Development at Wave Life Sciences, with extensive experience in designing tagged libraries for hit generation and managing laboratory operations. He holds a Ph.D. in Organic Chemistry from Dartmouth College and has held various scientific roles at Ensemble Therapeutics and other companies.
Current Role at Wave Life Sciences
Frank F. holds the position of Associate Director of Process Development at Wave Life Sciences. He has been with the company since 2017, contributing to the development of innovative therapeutic solutions. His role involves overseeing various aspects of process development, ensuring that projects align with the company's strategic goals.
Previous Experience at Ensemble Therapeutics Corporation
Prior to his current role, Frank F. worked at Ensemble Therapeutics Corporation for a total of 11 years. He served as a Senior Scientist from 2005 to 2007 and then progressed to Principal Scientist from 2007 to 2016. During his tenure, he focused on research and development in the field of therapeutics, contributing to the advancement of the company's scientific objectives.
Educational Background
Frank F. earned his Doctor of Philosophy (Ph.D.) in Organic Chemistry from Dartmouth College, where he studied from 1997 to 2002. He also holds a Bachelor of Arts (BA) in Chemistry and Biochemistry from Colby College, which he completed from 1992 to 1996. His educational background provides a strong foundation for his work in process development and scientific research.
Laboratory Management Experience
In addition to his research roles, Frank F. served as the chemical hygiene officer at Ensemble Therapeutics. In this capacity, he managed day-to-day laboratory operations, ensuring a safe and productive environment for all laboratory personnel. His responsibilities included overseeing compliance with safety regulations and promoting best practices in laboratory management.
Career Timeline
Frank F. has a diverse career in the biotechnology and pharmaceutical sectors. He began his professional journey at NeoGenesis Pharmaceuticals as a Senior Scientist from 2002 to 2003, followed by a role at Helicon Therapeutics Inc from 2003 to 2005. His extensive experience spans various positions, highlighting his expertise in scientific research and process development.